Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Instagram
  • Listen to CMAJ podcasts
Letters

Lifestyle drugs

Anton R. Miller
CMAJ July 24, 2001 165 (2) 153-153-a;
Anton R. Miller
Department of Pediatrics University of British Columbia Vancouver, BC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

I congratulate Joel Lexchin on his well-informed and thoughtful analysis of issues relating to lifestyle drugs.1 Producing a medical definition for “problems for living” and establishing boundaries for treatment represent major challenges. Many conditions uncomfortably straddle the medical–biological and environmental–social domains. Contemporary North American psychiatry, armed with a powerful tool in its Diagnostic and Statistical Manual of Mental Disorders (DSM-IV),2 presents a number of examples.

Under the banner of attention-deficit/hyperactivity disorder, the medical community has shown an ever- increasing tendency to use medications to “normalize” children whose behavioural and learning difficulties may, in an unknown proportion of cases, have as much to do with prevailing expectations and the resources available to today's families and schools as to neurobiology.3 Similarly, we increasingly use selective serotonin reuptake inhibitors to treat adults whose minor depressions and dysphoric moods may be as attributable to the subtle yet relentless pressures that are part of life in contemporary industrialized societies as to biological dysfunction.

Physicians who unquestioningly adhere to models of biological causation and medical treatment may be complicit in suppressing the need to question the effects of social and economic structures and values on people and may unwittingly obstruct needed social change.4

References

  1. 1.↵
    Lexchin J. Lifestyle drugs: issues for debate. CMAJ 2001;164(10):1449-51.
    OpenUrlFREE Full Text
  2. 2.↵
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington; The Association; 1994.
  3. 3.↵
    Diller LH. Running on Ritalin. New York: Bantam Books; 1998.
  4. 4.↵
    Vimpani GV. Prescribing stimulants for disruptive behaviour disorders: sometimes against the best interest of the child. J Paediatr Child Health 1997;33:9-11.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

CMAJ
Vol. 165, Issue 2
24 Jul 2001
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Lifestyle drugs
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Lifestyle drugs
Anton R. Miller
CMAJ Jul 2001, 165 (2) 153-153-a;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Lifestyle drugs
Anton R. Miller
CMAJ Jul 2001, 165 (2) 153-153-a;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • A call to reconsider the new diagnostic criteria for gestational diabetes mellitus
  • The 5 Ps need an update: toward a comprehensive sexual history
  • Don’t ignore perimenopause
Show more Letters

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected]

CMA Civility, Accessibility, Privacy

 

Powered by HighWire